Subscribe to
this category


A total of 76 posts are filed under Deals
Acadia Enters License Agreement with Neuren Worth up to $465 Million for Experimental Rett Syndrome Drug
Rare Daily Staff Acadia Pharmaceuticals entered into an exclusive North American license agreement with Neuren Pharmaceuticals for the… Continue Reading
Mallinckrodt Forms Rare Disease Research Partnership with Washington University
Rare Daily Staff Specialty pharmaceutical company Mallinckrodt said it have formed a rare disease research partnership with Washington… Continue Reading
Partnership Formed to Develop Gene Therapy for Cystic Fibrosis
Rare Daily Staff Oxford BioMedica said it has entered into a process development collaboration agreement with the UK Cystic Fibrosis Gene… Continue Reading
Akcea and PTC Collaborate to Commercialize Rare Disease Drugs in Latin America
Rare Daily Staff PTC Therapeutics and Akcea Therapeutics said they will collaborate to commercialize two of Akcea’s rare disease drugs… Continue Reading
AI Collaboration to Focus on DMD and Other Rare Diseases
Rare Daily Staff Insilico Medicine and A2A Pharmaceutics, two companies that harness artificial intelligence to improve the drug discovery… Continue Reading
Sobi to Acquire Global Rights for HLH Drug from Novimmune
Rare Daily Staff Sobi said it entered into a strategic partnership with Novimmune to develop and commercialize emapalumab, a late-stage… Continue Reading
EUSA Pharma to Acquire Castleman’s Disease Drug from Janssen Sciences Ireland for $115M
Rare Daily Staff EUSA Pharma it has agreed to pay Janssen Sciences Ireland UC $115 million to acquire the global rights to Sylvant, a… Continue Reading

Follow us on Twitter